Filed: 5/15/2025ACC: 0001104659-25-048969
📋 What this filing means
DCVC OPPORTUNITY FUND II GP, LLC filed this quarterly 13F‑HR report disclosing 2 equity positions with a total reported market value of $81.48M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
2
Positions
$81.48M
Total AUM (reported)
7.34M
Total Shares
Allocation by class
COM$60.58M74.3%
CL A$20.90M25.7%
Portfolio Concentration
Top 3$81.48M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 7.34M
Sole
Full voting authority
7.34M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole2
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings2
Rows:
Rocket Lab USA, Inc.
SOLEShares3.39M
TypeSH
Market value$60.58M
74.35%
Sole
3.39M
Shared
0.00
None
0.00
Recursion Pharmaceuticals, Inc.
SOLEShares3.95M
TypeSH
Market value$20.90M
25.65%
Sole
3.95M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Rocket Lab USA, Inc.SOLE | COM | 3.39M | SH | $60.58M 74.35% | 3.39M | 0.00 | 0.00 |
Recursion Pharmaceuticals, Inc.SOLE | CL A | 3.95M | SH | $20.90M 25.65% | 3.95M | 0.00 | 0.00 |